Spark Biomedical Sets Sights on Global Expansion with New ISO 13485 and MDSAP Certifications
18. November 2024 10:48 ET
|
Spark Biomedical
Dallas, TX, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Spark Biomedical, a leading developer of wearable neurostimulation devices, proudly announces the recent achievement of ISO 13485:2016 and MDSAP Quality...
Statement on Fentanyl “Exposure” Laws Issued by the American College of Medical Toxicology
04. November 2024 11:57 ET
|
American College of Medical Toxicology
Phoenix, AZ, Nov. 04, 2024 (GLOBE NEWSWIRE) -- In the recently issued, “Statement on Fentanyl “Exposure” Laws,” the American College of Medical Toxicology (ACMT) expresses concern regarding...
Communities Across New Jersey Rally for Ninth Annual Knock Out Opioid Abuse Day
31. Oktober 2024 11:05 ET
|
Partnership for a Drug-Free New Jersey
Millburn, NJ, Oct. 31, 2024 (GLOBE NEWSWIRE) -- New Jersey organizations, law enforcement representatives and residents united earlier this month to educate their communities about the opioid...
Emergent BioSolutions Demonstrates Commitment to Increasing Access & Awareness of NARCAN® Nasal Spray to Help Combat the Opioid Epidemic
08. Oktober 2024 17:32 ET
|
Emergent BioSolutions
Ongoing support of the ‘White House Challenge to Save Lives from Overdose’ through workplace and public safety measuresOne-year mark of Ready to Rescue public awareness campaign to expand awareness,...
Spark Biomedical Awarded National Institute on Drug Abuse Funding to Develop AI-Algorithm for Opioid Withdrawal and Cravings Detection
12. September 2024 13:39 ET
|
Spark Biomedical
Dallas, TX, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Spark Biomedical, a leader in wearable neurostimulation technology, is partnering with prestigious research and behavioral health institutes, Battelle...
FORE Awards $1 Million in New Grants to Strengthen State Initiatives to Combat the Opioid and Overdose Crisis
05. September 2024 10:06 ET
|
Foundation for Opioid Response Efforts
New York, Sept. 05, 2024 (GLOBE NEWSWIRE) -- As the opioid and overdose crisis continues to impact individuals and families across the country, the Foundation for Opioid Response Efforts (FORE)...
Emergent BioSolutions Expands Ready to Rescue Initiative to Support Widespread Opioid Emergency Preparedness
30. August 2024 08:16 ET
|
Emergent BioSolutions
For the second year, Emergent is teaming up with pro football legend, Emmitt Smith, to educate communities on opioid risks and how to be prepared with NARCAN® Nasal SprayIn recognition of...
FFF Enterprises Celebrates 36 Years of Patient-Centered Care
09. Juli 2024 13:34 ET
|
FFF Enterprises.com
TEMECULA, Calif., July 09, 2024 (GLOBE NEWSWIRE) -- FFF Enterprises, Inc., recognized as the nation's most trusted specialty drug distributor and diversified healthcare company, celebrates 13,151...
Qualifacts and MethodOne by Computalogic Partner to Elevate Controlled Medication Dispensing for Substance Use Disorders
08. Juli 2024 09:22 ET
|
Qualifacts
Nashville, Tenn., July 08, 2024 (GLOBE NEWSWIRE) -- Qualifacts, the leading provider of end-to-end electronic health record (EHR) software and data solutions for behavioral healthcare...
Foundation for Opioid Response Efforts (FORE) Announces $1.4 Million Grant to Equal Justice Works to Launch National Legal Fellowship Program
21. März 2024 10:30 ET
|
Foundation for Opioid Response Efforts
New York, March 21, 2024 (GLOBE NEWSWIRE) -- The Foundation for Opioid Response Efforts (FORE) today announced it is awarding a grant of $1,361,005 over 30 months to Equal Justice Works to launch a...